AVEO

AVEO Pharmaceuticals, Inc.

Delisted

AVEO was delisted on the 19th of January, 2023.

110 hedge funds and large institutions have $368M invested in AVEO Pharmaceuticals, Inc. in 2022 Q4 according to their latest regulatory filings, with 65 funds opening new positions, 23 increasing their positions, 12 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
110
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$6.02M
Puts
$194K
Net Calls
Net Calls Change

Top Buyers

1 +$21.9M
2 +$21.6M
3 +$19.4M
4
AllianceBernstein
AllianceBernstein
Tennessee
+$18.2M
5
MF
Magnetar Financial
Illinois
+$16.8M

Top Sellers

1 -$32.5M
2 -$30.6M
3 -$13.7M
4
WVP
Worth Venture Partners
New Jersey
-$7.69M
5
JGC
J. Goldman & Co
New York
-$5.4M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$343K
77
$327K
78
$315K
79
$300K
80
$252K
81
$235K
82
$233K
83
$227K
84
$209K
85
$207K
86
$206K
87
$167K
88
$167K
89
$150K
90
$140K
91
$130K
92
$123K
93
$112K
94
$95.8K
95
$46K
96
$35.4K
97
$29K
98
$14.9K
99
$11.6K
100
$9K